Schrodinger Stock News

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of -1.64% and 2.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at the Jefferies Healthcare Conference.

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Citi Biotech Virtual Co-Panel Day.

Schrödinger, Inc. (NASDAQ:SDGR ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Jaren Madden – Senior Vice President of Investor Relations and Corporate Affairs Ramy F

These hypergrowth stocks are bargains after retreating for much of the last year. They will all perform very well for long-term investors.

Schrödinger software platform makes it chiefly a healthcare technology company; however, the company is developing an impressive pipeline and list partners from their drug discovery efforts.

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present new preclinical data from its Wee1 Inhibitor Program at AACR Annual Meeting 2022.

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Truist Securities Life Sciences AI Symposium - Biotech & Tools.

Schrodinger Inc. (NASDAQ:SDGR) price closed higher on Friday, February 25, jumping 19.12% above its previous close. >> 5 Best Growth Stocks for 2022 << >> 5 Best Growth Stocks for 2022 << A look at the daily price movement shows that the last close reads $27.40, with intraday deals fluctuated between $29.40 and $34.25. The … These Numbers Show Just How Powerful Schrodinger Inc. (NASDAQ: SDGR) Stock ‎Is Read More »

In recent trading session, Schrodinger Inc. (NASDAQ:SDGR) saw 0.89 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $32.37 trading at $4.97 or 18.14% at last check today assigns it a market valuation of $2.03B. That most recent trading price of SDGR’s stock … Schrodinger Inc. (NASDAQ:SDGR) Is 28.51% Above Its 52-Week Low, But How Long Can It Continue? Read More »

Despite a mixed performance in its Q4 2021 results, Schrödinger <> is trading sharply higher in morning hours as Wall Street reacts to mid-term milestones unveiled by the health…

Aerie Pharmaceuticals (AERI) +25%. Schrodinger (SDGR) +17%. Baudax Bio BXRX -55%. The Joint (JYNT) -15%.

SDGR earnings call for the period ending December 31, 2021.

Schrodinger, Inc. (SDGR) CEO Ramy Farid on Q4 2021 Results - Earnings Call Transcript